To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)

This study has been completed.

Study NCT00992589 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: September 4, 2009 Last Updated: February 13, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2011
Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)